Evaluation of renal blood flow on men who administer tadalafil using contrast-enhanced ultrasound

Evaluation of renal blood flow on men who administer tadalafil using contrast-enhanced ultrasound - Evaluation of renal blood flow on men who administer tadalafil

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025060

Enrollment

Registered

2016-11-29

Start date

2015-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy patient

Interventions

abdominal echo

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healthy patient

Exclusion criteria

Exclusion criteria: medical care

Design outcomes

Primary

Measure	Time frame
Renal blood flow	—

Countries

Japan

Contacts

Public ContactRyoei Hara

Kawasaki medical shool urology

ryoeih@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026